Lenalidomide (Revlimid generic)

About Amneal Pharmaceuticals

Amneal Pharmaceuticals is a publicly traded, integrated biopharmaceutical company with a 20+ year history focused on expanding access to essential medicines. It operates across three core segments: Complex Generics, Biosciences (biosimilars and injectables), and Specialty branded pharmaceuticals, primarily in CNS and endocrine disorders. The company leverages over 1 million square feet of U.S. manufacturing capacity, has a robust pipeline with 69 pending ANDAs, and is led by its founding Patel brothers, aiming to bring manufacturing of critical medicines back to the United States.

About Natco Pharma

Natco Pharma Limited is a vertically integrated pharmaceutical company with a mission to improve patient access to high-quality, affordable medicines. The company has established itself as a leader in the Indian generics market, with significant achievements in developing and commercializing complex generics, including oncology drugs like lenalidomide and hepatitis C treatments. Its strategic direction focuses on expanding its branded generics portfolio, strengthening its API business, and pursuing growth in regulated markets like the US through its subsidiary Natco Pharma USA.

Therapeutic Areas

Other Oncology Drugs